An experimental treatment for type 2 diabetes developed by Johnson & Johnson proved effective at reducing blood sugar in patients on long-term insulin therapy and at high risk for heart problems, according to a study presented on Tuesday.
Johnson & Johnson is close to concluding its global review of creative responsibilities for its over-the-counter brands and sources expect the bulk of the business to be consolidated at three roster shops: DDB, BBDO and JWT.
Johnson & Johnson, the giant health care products maker, reported Tuesday that its third-quarter profit fell 7 percent as litigation and acquisition costs and factory upgrade expenses offset higher medicine and medical device sales.
Johnson & Johnson has concluded its global creative agency review and is preparing to launch a global media review in markets not already in review, including North America, company executives said today.
Johnson & Johnson has made headlines over the past couple of years - for all the wrong reasons. Plagued by quality control problems and costly product recalls affecting key brands such as Tylenol, Benadryl and Motrin, the health care giant's reputation ...
Residents, students and employees of Lake Nona are about to become the center of a long-term study that may reveal the secret to living a longer, healthier life, executives from Johnson & Johnson and Lake Nona Institute announced today.